Submitted by Anonymous (not verified) on 4 August 2025 - 15:40
Human medicines European public assessment report (EPAR): Vitrakvi, larotrectinib, Date of authorisation: 19/09/2019, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Vitrakvi, larotrectinib, Date of authorisation: 19/09/2019, Revision: 14, Status: Authorised